Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients.

Min-Kyung Kim,Kyung-Shin Lee,Sin Young Ham,Youn Young Choi,Eunyoung Lee,Seungjae Lee,Bora Lee,Jaehyun Jeon,BumSik Chin,Yeonjae Kim,Gayeon Kim,Hee-Chang Jang,Jae-Phil Choi,Sang-Won Park

Journal of Korean medical science（2023）

引用 0|浏览15

暂无评分

摘要

Nirmatrelvir-ritonavir treatment significantly reduced oxygen therapy requirements in high-risk patients with COVID-19 during the omicron variant surge in South Korea. Physicians are encouraged to consider the active use of nirmatrelvir-ritonavir and to be watchful for gastrointestinal symptoms during medication.

查看译文

关键词

Nirmatrelvir-Ritonavir, COVID-19, Effectiveness, Retrospective Cohort Study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要